[
  {
    "ts": "2026-02-17T05:31:47+00:00",
    "headline": "The Top 5 Analyst Questions From CVS Health’s Q4 Earnings Call",
    "summary": "CVS Health’s fourth quarter results reflected steady execution across its pharmacy, health services, and insurance businesses, with management crediting improvements in operational efficiency and customer experience as key drivers. CEO David Joyner highlighted the completed transition to a cost-based reimbursement model and successful integration of Rite Aid assets as important milestones, noting, “We have successfully completed the transition to a cost-based reimbursement. This was a significan",
    "url": "https://finance.yahoo.com/news/top-5-analyst-questions-cvs-053147157.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "9e982a8a-19a4-3c0a-83e4-a6b9266f9b89",
      "content": {
        "id": "9e982a8a-19a4-3c0a-83e4-a6b9266f9b89",
        "contentType": "STORY",
        "title": "The Top 5 Analyst Questions From CVS Health’s Q4 Earnings Call",
        "description": "",
        "summary": "CVS Health’s fourth quarter results reflected steady execution across its pharmacy, health services, and insurance businesses, with management crediting improvements in operational efficiency and customer experience as key drivers. CEO David Joyner highlighted the completed transition to a cost-based reimbursement model and successful integration of Rite Aid assets as important milestones, noting, “We have successfully completed the transition to a cost-based reimbursement. This was a significan",
        "pubDate": "2026-02-17T05:31:47Z",
        "displayTime": "2026-02-17T05:31:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CVS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TljU2TKBBw.om82sijmNHg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdlNJA5IleaBBwQa3TKTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-cvs-053147157.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-cvs-053147157.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]